Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Konstantinjuk, P; Schrenk, P; Reitsamer, R; Koeberle-Wuehrer, R; Tausch, C; Roka, S; Riedle, O; Poestiberger, S; Hecke, D; Janauer, M; Haid, A.
A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
BREAST. 2007; 16(5): 520-526. Doi: 10.1016/j.breast.2007.04.001
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Konstantiniuk Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Introduction: In many countries sentinel node biopsy (SNB) has become the standard of care in breast cancer based on a large number of observational studies but without results from prospective randomized trials. The goat of our study was to evaluate the oncological safety of the SNB in breast cancer in a multicenter, norrandomized setting with comparable groups. Patients and methods: Between 1996/05 and 2004/11, 2942 patients from 14 departments in Austria with unicentric, unilateral, invasive disease without neoadjuvant therapy were collected in a database. The recommendations of the Austrian Sentinel Node Study Group were to complete a training period (phase 1) with 50 cases of SNB followed by axillary lymph node dissection (ALND) to prove a detection rate of >= 90% and a fatse-negative rate of <= 5%. In the executing period (phase 11), SNB was followed by ALND only if the sentinel node (SN) contained metastases. We compared the results on disease-free survival, local recurrence rates, distant recurrence rates and overall survival of both groups. Cases from phases I and II generated groups 1 (n = 671) and 2 (n = 2271 cases), respectively. Results: Overall mean follow-up time: 34.41 months [GRAPHICS] Conclusion: SNB followed by ALND only in cases with metastases in the SN is a safe procedure and at least equal to ALND in all cases. (c) 2007 Elsevier Ltd. All rights reserved.
Find related publications in this database (using NLM MeSH Indexing)
Austria -
Axilla - pathology
Breast Neoplasms - mortality
Disease-Free Survival - mortality
Female - mortality
Humans - mortality
Lymph Node Excision - mortality
Lymph Nodes - pathology
Lymphatic Metastasis - pathology
Middle Aged - pathology
Neoplasm Recurrence, Local - mortality
Neoplasm Staging - mortality
Predictive Value of Tests - mortality
Sensitivity and Specificity - mortality
Sentinel Lymph Node Biopsy - mortality
Survival Analysis - mortality

Find related publications in this database (Keywords)
breast cancer
sentinel node biopsy
follow-up
recurrences
disease-free survival
overall survival
© Med Uni GrazImprint